SCHEMBL3790795

SCHEMBL3790795

Nc1ccc(-c2ccccc2N)cc1Oc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.48
▸ HSD17B10 Q99714 2/20 0.48
▸ CYP3A4 P08684 2/20 0.45
▸ NCOA1 Q15788 1/20 0.45
▸ NCOA3 Q9Y6Q9 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ IKBKB O14920 1/20 0.44
▸ BRAF P15056 1/20 0.44
▸ GAA P10253 2/20 0.44
▸ BRD4 O60885 2/20 0.43
▸ DHFR P00374 1/20 0.43
▸ RCE1 Q9Y256 1/20 0.42
▸ GSTP1 P09211 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ PTGS2 P35354 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30697305 0.87 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL5014782 0.87 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL3784995 0.86 CYP1A2 (0.57) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL30393911 0.85 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL3782732 0.84 CYP3A4 (0.49) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL30394034 0.82 CYP3A4 (0.47) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL3793152 0.81 MAOA (0.53) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL31019387 0.81 MAOA (0.53) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL11135655 0.80 IKBKB (0.60) ALDH1A1HSD17B10CYP3A4NCOA1NCOA3
SCHEMBL398444 0.80 ALDH1A1 (0.64) ALDH1A1HSD17B10NCOA1NCOA3GSTP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 — — US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885HSD17B10 1100/4885CYP3A4 177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback